Modified Hemoglobin as Red Blood Cell Substitutes

References

• Amberson W R. Blood substitute. Biol. Rev 1937; 12: 48
   Google Scholar
• Rabiner S F, Helbert J R, Lopas H, Friedman L H. Evaluation of stroma free hemoglobin solution as a plasma expander. J Exp Med 1967; 126: 1127
   PubMed Web of Science ®Google Scholar
• Moss G S, DeWoskin R, Rosen A L, Levine H, Palani C K. Transport of oxygen and carbon dioxide by hemoglobin-saline solution in the red cell-free primate. Surg Gynecol Obstet 1976; 142: 357
   PubMedGoogle Scholar
• DeVenuto F, Zuck T F, Zegna A I, Moores W Y. Characteristics of stromafree hemoglobin prepared by crystallization. J Lab Clin Med 1977; 89: 509
   PubMed Web of Science ®Google Scholar
• Savitsky J P, Doozi J, Black J, Arnold J D. A clinical safety trial of stroma free hemoglobin. Clin Pharm Ther 1978; 23: 73
   PubMed Web of Science ®Google Scholar
• Chang T MS. Hemoglobin corpuscles. Report of a research project of B.Sc. Honours Physiology 1957; McGill University: 1–25
   Google Scholar
• Chang T MS. Semipermeable microcapsules. Science, 146(524)1964
   Google Scholar
• Chang T MS. Semipermeable aqueous microcapsules (Ph.D. Thesis). McGill University, MontrealCanada 1965
   Google Scholar
• Chang T MS, MacIntosh F C, Mason S G. Semipermeable aqueous microcapsules: I. Preparation and properties. Can. J. Physiol. Pharmacol. 1966; 44: 115–128
   PubMed Web of Science ®Google Scholar
• Chang T MS. Artificial cells. Charles C Thomas, Springfield, IL 1972
   Google Scholar
• Chang T MS. Artificial cells: biotechnology and medical applications. Appl Biochem & Biotechnol 1984; 10: 5
   PubMed Web of Science ®Google Scholar
• Chang T MS. Artificial red blood cells. Trans. Am. Soc. Artif. Int. Organs 1980; 26: 354–357
   Google Scholar
• Djordjevich L, Miller I. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp. Hematol 1980; 8: 584
   PubMed Web of Science ®Google Scholar
• Masayuki A, Kato A, Kondo T. Preparation and biophysical properties of hemolysate loaded liposomes. In Microencapsulation Including Artificial Cells, T. Chang. Humana Press, New York 1984; 143–146
   Google Scholar
• Hunt A C, Burnette R R. Neohemocytes. In Advances in Blood Substitute Research, R B Bolin, R P Geyer, G J Nemo. Alan R Lisa Inc, New York 1983; 59–70
   Google Scholar
• Gaber B P, Farmer M C. Encapsulation of hemoglobin in phospholipid vesicles: preparation and properties of a red blood cell surrogate. Prog. Clin. Biol. Res. 1984; 165: 179–190
   PubMedGoogle Scholar
• Bunn H F, Jandl J H. The renal handling of hemoglobin. Trans Assoc Am Physicians 1968; 81: 147
   PubMedGoogle Scholar
• Mok W, Chen D E, Mazur A. Covalent linkage of subunits of hemoglobin. Fed Proc 1975; 34: 1458
   PubMedGoogle Scholar
• Tam S C, Blumenstein J, Wong J T. Dextran hemoglobin. Proc Natl Acad Sci USA 1976; 73: 2128
   PubMed Web of Science ®Google Scholar
• Benesch R, Benesch R E, Yung S, Edalji R. Hemoglobin covalently bridged across the polyphosphate binding site. Biochem Biophys Res Commun 1975; 63: 1123
   PubMed Web of Science ®Google Scholar
• Greenburg A G, Hayashi R, Krupenas I. Intravascular persistence and oxygen delivery of pyridoxalated stroma-free hemoglobin during gradations of hypotension. Surgery 1979; 86: 13
   PubMed Web of Science ®Google Scholar
• Sehgal L R, Rosen A L, Gould S A, Sehgal H L, Dalton L, Mayoral J, Moss G S. In vitro and in vivo characteristics of polymerized pyridoxalated hemoglobin solution. Fed Proc 1980; 39: 2383
   Google Scholar
• Dudziak R, Bonhard K. The development of hemoglobin preparations for various indications. Anesthesist 1980; 29: 181
   PubMed Web of Science ®Google Scholar
• DeVenuto F, Zegna A I. Blood exchange with pyridoxalated-polymerized hemoglobin. Surg Gynecol Obstet 1982; 155: 342
   PubMedGoogle Scholar
• Keipert P E, Minkowitz J, Chang T MS. Cross-linked stroma-free polyhemoglobin as a potential blood substitute. Int. J. Artif. Organs, 5(383)1982
   Google Scholar
• Sehgal L R, Rosen A L, Gould S A, Sehgal H L, Moss G S. Preparation and in vitro characteristics of polymerized pyridoxalated hemoglobin. Transfusion, 23(158)1983
   Google Scholar
• Sehgal L R, Gould S A, Rosen A L, Sehgal H L, Moss G S. Polymerized pyridoxalated hemoglobin: a red cell substitute with normal oxygen capacity. Surgery, 95(433)1984
   Google Scholar
• Keipert P E, Chang T MS. In vivo assessment of pyridoxalated crosslinked polyhemoglobin as an artificial red cell substitute in rats. Trans. Am Soc. Artif. Intern. Organs 1983; 29: 329
   PubMedGoogle Scholar
• Keipert P E, Chang T MS. Preparation and in-vitro characteristics of pyridoxalated polyhemoglobin as blood substitute. Appl Biochem & Biotechnol 1984; 10: 133
   PubMed Web of Science ®Google Scholar
• Keipert P E. Chang TMS. pyridoxalated polyhemoglobin as a blood substitute for resuscitation of lethal hemorrhagic shock in conscious rats. Biomat. Med. Dev. Artif. Organs 1985; 13: 1–15
   Google Scholar
• Hobbhahn J, Vogel H, Kothe N, Brendel W, Keipert P, Jesch F. Hemodynamics and transport after partial and total blood exchange with pyridoxalated polyhemoglobin in dogs. Acta Anesth. Scand. 1985; 29: 537–543
   PubMed Web of Science ®Google Scholar
• Marks D H, Patressi J, Chaudry I T. Effects of pyridoxalated stabilized stroma-free hemoglobin solution on the clearance of intravascular lipid by the reticuloendothelial system. Circ. Shock. 1985; 16: 165–172
   PubMedGoogle Scholar
• Stabilini R, Palazzini G, Pietta G P, Pace M, Calatroni A, Raffaldoni E, Ghessi A, Aguggini G, Agostoni A. A pyridoxalated polymerized hemoglobin solution as oxygen carrying substitute. Int. J. Artif. Organs, 6(319)1983
   Google Scholar
• Feola M, Gonzalez H, Canizaro P C, Bingham D. Development of bovine stroma-free hemoglobin solution as a blood substitute. Surgery Gynecology & Obstetrics 1983; 157: 399
   PubMedGoogle Scholar
• Maffuid P W, Greenburg A G, Lee E S, Velky T, Hoyt D B. Modification of stroma free hemoglobin: chemistry and efficacy. Am. College. Surg. Forum 1983; 34: 5
   Google Scholar
• Hsia J C, Hayes T M. Separation of glyoxylated hemoglobin with varying oxygen affinity by polyanion fast protein liquid chromatography. J. Chromatography 1984; 303: 425
   PubMedGoogle Scholar
• Hertzman C M, Keipert P E, Chang T MS. Serum antibody titers in rats receiving repeated small subcutaneous injections of hemoglobin or polyhemoglobin: a preliminary report. Int. J. Artif. Organs 1986; 9: 179–182
   PubMed Web of Science ®Google Scholar
• Chang T MS, Varma R. Pyridoxalated heterogenous and homologous polyhemoglobin and hemoglobin: systemic effects of replacement transfusion in rats previously received immunising doses. Biomaterial, Artificial Cells and Artificial Organs. 1987; 15
   Google Scholar
• Clark L C, Jr, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966; 152: 1755
   PubMed Web of Science ®Google Scholar
• Chang T MS. Semipermeable aqueous microcapsules (“artificial cells”.): with emphasis on experiments in an extracorporeal shunt system. Trans Am. Soc. Artif. Intern. Organs 1966; 12: 13
   PubMedGoogle Scholar
• Sloviter H, Kamimoto T. Erythrocyte substitute for perfusion of brain. Nature 1967; 216: 458
   PubMed Web of Science ®Google Scholar
• Geyer R P, Monroe R G, Taylor K. Survival of rats totally perfused with a fluorocarbon-detergent preparation. In Organ Perfusion and Preservation, J C Norman, J Folkman, W G Hardison, L E Rudolf, F J Veith. Appleton Century Crofts, New York 1968; 85–96
   Google Scholar
• Naito R, Yokoyama K. An improved perfluorodecalin emulsion. In Blood Substitutes and Plasma Expanders, G A Jamieson, T J Greenwalt. Alan R Liss Inc, New York 1978; 81
   Google Scholar
• Ohyanagi H, Toshima K, Sekita M, Okamoto M, Itoh T, Mitsuno T, Naito R, Suyama T, Yokoyama K. Clinical study of perfluorochemical whole blood substitute. Clinical Therapeutics 1979; 2: 306
   Web of Science ®Google Scholar